Feb 24 (Reuters) - Probiotec (PBP) :
- GROSS MARGINS EXPECTED TO REVERSE PROGRESSIVELY OVER SECOND HALF OF FY23
- BOARD EXPECTS TO DELIVER SALES OF A$205M TO A$215M FOR FY23
- BOARD EXPECTS TO DELIVER EBITDA OF A$34.5M TO A$36.0M FOR FY23
News: PBP Probiotec Says Gross Margins Expected To Reverse Progressively Over Second Half
Add to My Watchlist
What is My Watchlist?